Ambroxol, 7.5 mg/ml 4 ml 10 pcs

Studies have shown that the active ingredient of the drug, ambroxol, increases secretion in the respiratory tract. It increases the production of pulmonary surfactant and stimulates ciliary activity.

Indications

Acute and chronic diseases of the respiratory tract with the release of viscous sputum: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease, bronchial asthma with difficulty in sputum discharge, bronchiectasis.

Pharmacological effect

Studies have shown that the active ingredient of the drug, ambroxol, increases secretion in the respiratory tract. It enhances the production of pulmonary surfactant and stimulates ciliary activity.

Active ingredient

Ambroxol

Composition

Active ingredient:

Contraindications

Hypersensitivity to ambroxol or other components of the drug, pregnancy (first trimester), lactation period.

Interaction

No clinically significant, undesirable interactions with other drugs have been reported.

Overdose

Specific symptoms of overdose in humans have not been described.

Manufacturer

Update of PFC JSC, Russia